Is Gilead Sciences a Great Dividend Stock?
HIV
sales were up 12% in 2019 and 2018, but if that starts to slow down, it could
lead to problems down the road for Gilead's bottom line, and in turn,
its ...
|
View article...
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.
HIV
sales were up 12% in 2019 and 2018, but if that starts to slow down, it could
lead to problems down the road for Gilead's bottom line, and in turn,
its ...
|